Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy

The recent outbreak of coronavirus disease 2019 (COVID-19) by SARS-CoV-2 has led to uptodate 24.3 M cases and 0.8 M deaths. It is thus in urgent need to rationalize potential therapeutic targets against the progression of diseases. An effective, feasible way is to use the pre-existing ΔORF6 mutant o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Henry Sung-Ching, Guo, Chin-Lin, Lin, Gan-Hong, Lee, Kang-Yun, Okada, Yukinori, Chang, Wei-Chiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817445/
https://www.ncbi.nlm.nih.gov/pubmed/33482326
http://dx.doi.org/10.1016/j.ygeno.2020.12.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817445/
https://www.ncbi.nlm.nih.gov/pubmed/33482326
http://dx.doi.org/10.1016/j.ygeno.2020.12.041

Ejemplares similares